LL-37observational2000

Synergistic actions of antibacterial neutrophil defensins and cathelicidins.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]

confidence

Key findings

Defensins (HNP-1, GNCPs) lose activity in 150 mM NaCl but synergize with NaCl-resistant cathelicidins (LL-37, CAP11) to enhance antibacterial activity and membrane permeabilization.

View source on PubMed (PMID 10738945) ↗

Sample size
Not applicable (in vitro)
Population
In vitro bacterial cultures (E. coli, S. aureus, E. coli ML-35p) with human and guinea pig peptides
Dosing
0.1-10 µg/ml
Duration
Not reported
Route
in vitro
Blinding
not_reported
Controls
none
Drug class
antimicrobial peptide

Measured endpoints

  • Antibacterial activity against E. coli and S. aureus (synergy of defensins with cathelicidins in 150 mM NaCl)Increasedantimicrobial
    significant
  • Antibacterial activity of HNP-1 and GNCPs in absence of NaClIncreasedantimicrobial
    not_reportedeffect: dose-dependent (0.1-10 µg/ml)
  • Antibacterial activity of HNP-1 and GNCPs in presence of 150 mM NaClDecreasedantimicrobial
    not_reportedeffect: completely lost
  • Antibacterial activity of CAP18/LL-37 and CAP11 in presence of NaCl (NaCl resistance)No changeantimicrobial
    not_reportedeffect: resistant to NaCl
  • Outer and inner membrane permeabilization of E. coli ML-35p (synergy)Increasedantimicrobial
    significant
Full abstract

Activated neutrophils extracellularly release antibacterial defensins and cathelicidins from the granules. In this study, to elucidate the interactions between defensins and cathelicidins in the extracellular environment, we evaluated the individual and synergistic actions of defensins and cathelicidins in the presence of physiological concentration of NaCl (150 mM). Antibacterial activities against Escherichia coli and Staphylococcus aureus were assessed using human and guinea pig defensins and cathelicidins. Furthermore, the effect of defensins and cathelicidins on membrane permeabilization was examined using E. coli ML-35p, as a target organism. In the absence of NaCl, human defensin (HNP-1) and guinea pig defensins (GNCPs) exhibited the antibacterial activities in a dose-dependent manner (0.1-10 microg/ml); however, their activities were completely lost in the presence of 150 mM NaCl. In contrast, the antibacterial activities of human cathelicidin (CAP18/LL-37) and guinea pig cathelicidin (CAP11) were resistant to NaCl. Interestingly, HNP-1 and GNCPs synergized with CAP18/LL-37 and CAP11 to enhance the antibacterial activities against E. coli and S. aureus in the presence of 150 mM NaCl (p<0.05). Similarly, HNP-1 and GNCPs were synergistic with CAP18/LL-37 and CAP11 to potentiate the outer and inner membrane permeabilization of E. coli ML-35p (p<0.05). Together these observations indicate that when extracellularly released from neutrophils, defensins cannot function as antibacterial molecules by themselves, but can synergistically work with cathelicidins to exert the antibacterial activity in the extracellular milieu by augmenting the membrane permeabilization of target cells.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.